Cardiome Pharma Corporation (NASDAQ:CRME) reported earnings of ($0.26) per share missing Walls Streets expectations.

Cardiome Pharma Corporation (NASDAQ:CRME) reported 6/30/2017 earnings this Afternoon, coming in at ($0.26) per share, missing Wall Street’s estimates of ($0.17) per Share. Revenue for the quarter came in at $5.75 million missing the streets estimates of $6.88 million

Story continues below

Analyst Coverage For Cardiome Pharma Corporation (NASDAQ:CRME)
These are 1 Hold Rating, 5 Buy Ratings .
The current consensus rating for Cardiome Pharma Corporation (NASDAQ:CRME) is Buy (Score: 2.83) with a consensus target price of $6.65 , a potential (61.80% upside)



      Recent Trading for Cardiome Pharma Corporation (NASDAQ:CRME)
      Shares of Cardiome Pharma Corporation closed the previous trading session at 4.11 down -0.08 -1.91% with 36,768 shares trading hands.

      An ad to help with our costs